Precision Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Precision BioSciences
DTIL Stock  USD 4.07  0.31  8.24%   
Precision BioSciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Precision BioSciences' valuation are provided below:
Gross Profit
698 K
Market Capitalization
98 M
Enterprise Value Revenue
117.4632
Revenue
698 K
Earnings Share
(8.96)
There are over one hundred nineteen available trending fundamental ratios for Precision BioSciences, which can be analyzed over time and compared to other ratios. We recommend to check out Precision BioSciences' recent fundamental drivers against the all of the trends between 2010 and 2026. The value of Market Cap is estimated to slide to about 28.4 M. Enterprise Value is expected to rise to about (32.6 M) this year

Precision BioSciences Total Revenue

40.21 Million

Check Precision BioSciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Precision BioSciences' main balance sheet or income statement drivers, such as Interest Income of 8.2 M, Depreciation And Amortization of 6.3 M or Interest Expense of 2.2 M, as well as many indicators such as Price To Sales Ratio of 0.41, Dividend Yield of 0.0 or PTB Ratio of 0.44. Precision financial statements analysis is a perfect complement when working with Precision BioSciences Valuation or Volatility modules.
  
Build AI portfolio with Precision Stock
Check out the analysis of Precision BioSciences Correlation against competitors.
For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.

Precision BioSciences Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets176.1 M156.8 M139.1 M
Slightly volatile
Other Current Liabilities8.3 M10.8 M5.4 M
Slightly volatile
Total Current Liabilities32 M17.2 M21.3 M
Slightly volatile
Other Liabilities64.4 M83.8 M86.3 M
Slightly volatile
Property Plant And Equipment Net22.2 M11.7 M13.9 M
Slightly volatile
Current Deferred Revenue3.2 M3.4 M11.4 M
Pretty Stable
Accounts Payable1.3 M1.2 M1.4 M
Very volatile
Cash130.3 M98.8 M109.1 M
Slightly volatile
Non Current Assets Total33.6 M47.6 M22.4 M
Slightly volatile
Non Currrent Assets Other33.1 M31.5 M7.9 M
Slightly volatile
Other Assets1.091.151.9 M
Slightly volatile
Cash And Short Term Investments130.3 M99.3 M109.2 M
Slightly volatile
Net Receivables3.4 M2 M2.1 M
Slightly volatile
Common Stock Shares Outstanding3.4 M6.2 M8.7 M
Slightly volatile
Liabilities And Stockholders Equity176.1 M156.8 M139.1 M
Slightly volatile
Non Current Liabilities Total67.6 M58.5 M85.6 M
Slightly volatile
Capital Surpluse591.3 M563.2 M230.2 M
Slightly volatile
Other Current Assets8.8 M8 M5.4 M
Slightly volatile
Other Stockholder Equity335.4 M619.7 M222.3 M
Slightly volatile
Total Liabilities125 M92 M109.3 M
Slightly volatile
Total Current Assets142.5 M109.2 M116.7 M
Slightly volatile
Intangible Assets1 M715.3 K698.6 K
Slightly volatile
Property Plant Equipment25 M23.2 M15.8 M
Slightly volatile
Property Plant And Equipment Gross40.7 M44 M25.8 M
Slightly volatile
Net Working Capital112.4 M92 M82.8 M
Slightly volatile
Short Term Debt1.4 M1.5 M3.3 M
Slightly volatile
Inventory11.1 M8.7 M9.4 M
Very volatile
Short and Long Term Debt Total23.3 M34.6 M15.8 M
Slightly volatile
Capital Lease Obligations6.2 M7 M9.2 M
Slightly volatile
Non Current Liabilities Other165.9 K174.6 K10.7 M
Pretty Stable
Long Term Debt17.2 M25.7 M8.2 M
Slightly volatile
Long Term Debt Total13.6 M25.6 M8 M
Slightly volatile
Common Stock800900982
Slightly volatile
Short and Long Term Debt17.9 M20.2 M22 M
Slightly volatile

Precision BioSciences Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income8.2 M7.8 M2.7 M
Slightly volatile
Depreciation And Amortization6.3 M5.3 M3.9 M
Slightly volatile
Selling General Administrative30.1 M40.6 M20.8 M
Slightly volatile
Total Revenue40.2 M79 M28.8 M
Slightly volatile
Gross Profit40.2 M79 M28.8 M
Slightly volatile
Other Operating Expenses94.9 M109.1 M63.2 M
Slightly volatile
Research Development64.7 M68.5 M42.2 M
Slightly volatile
Total Operating Expenses94.8 M109.1 M63 M
Slightly volatile
Net Interest Income6 M5.7 M2.3 M
Slightly volatile
Reconciled Depreciation7.1 M5.3 M4.4 M
Slightly volatile
Selling And Marketing Expenses3.4 M3.8 M4.2 M
Slightly volatile

Precision BioSciences Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow121.7 M134.2 M79.1 M
Slightly volatile
Depreciation6.3 M5.3 M3.9 M
Slightly volatile
Dividends Paid9.9 M11.2 M12.2 M
Slightly volatile
Capital Expenditures213.8 K225 K4.6 M
Very volatile
End Period Cash Flow133 M124.7 M112.2 M
Slightly volatile
Stock Based Compensation12.1 M14.5 M6.9 M
Slightly volatile
Issuance Of Capital Stock53.4 M45.2 M84.9 M
Slightly volatile
Cash Flows Other Operating16.3 M28.8 M13.6 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.410.44527
Slightly volatile
Days Sales Outstanding7.718.1226.9551
Pretty Stable
Stock Based Compensation To Revenue0.260.170.2169
Slightly volatile
Capex To Depreciation0.05970.06282.3398
Slightly volatile
Sales General And Administrative To Revenue1.170.591.1124
Slightly volatile
Research And Ddevelopement To Revenue0.951.01.815
Very volatile
Capex To Revenue0.0040.00420.3486
Pretty Stable
Cash Per Share13.814.5332.2735
Slightly volatile
Intangibles To Total Assets0.00640.00520.004
Slightly volatile
Current Ratio6.497.297.9283
Slightly volatile
Receivables Turnover82.5146.5353.7133
Pretty Stable
Graham Number11.1712.5613.71
Slightly volatile
Debt To Equity0.470.480.3681
Slightly volatile
Capex Per Share0.040.04212.3972
Very volatile
Revenue Per Share11.839.059.2058
Slightly volatile
Interest Debt Per Share4.424.192.5281
Slightly volatile
Debt To Assets0.10.20.0961
Slightly volatile
Operating Cycle7.718.1226.9551
Pretty Stable
Effective Tax Rate5.0E-45.0E-46.0E-4
Slightly volatile
Long Term Debt To Capitalization0.150.260.092
Slightly volatile
Total Debt To Capitalization0.250.310.2365
Slightly volatile
Debt Equity Ratio0.470.480.3681
Slightly volatile
Quick Ratio6.497.297.9283
Slightly volatile
Net Income Per E B T1.061.31.2604
Slightly volatile
Cash Ratio6.046.597.6029
Slightly volatile
Cash Conversion Cycle7.718.1226.9551
Pretty Stable
Days Of Sales Outstanding7.718.1226.9551
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio1.291.151.1087
Slightly volatile
Fixed Asset Turnover6.386.072.6241
Slightly volatile
Debt Ratio0.10.20.0961
Slightly volatile
Price Sales Ratio0.410.44527
Slightly volatile
Asset Turnover0.480.450.1949
Slightly volatile

Precision BioSciences Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap28.4 M29.9 M3.8 B
Slightly volatile

Precision Fundamental Market Drivers

Forward Price Earnings11.7786
Cash And Short Term Investments86.3 M

Precision Upcoming Events

14th of March 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
14th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Precision BioSciences Financial Statements

Precision BioSciences investors utilize fundamental indicators, such as revenue or net income, to predict how Precision Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue3.4 M3.2 M
Total Revenue79 M40.2 M
Cost Of Revenue5.3 M4 M
Stock Based Compensation To Revenue 0.17  0.26 
Sales General And Administrative To Revenue 0.59  1.17 
Research And Ddevelopement To Revenue 1.00  0.95 
Revenue Per Share 9.05  11.83 
Ebit Per Revenue(0.34)(0.36)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Precision BioSciences is a strong investment it is important to analyze Precision BioSciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Precision BioSciences' future performance. For an informed investment choice regarding Precision Stock, refer to the following important reports:
How To Invest In Precision
Details
Is Precision Stock a good investment?
Details
What is Precision BioSciences' Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Precision BioSciences Correlation against competitors.
For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precision BioSciences. Projected growth potential of Precision fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Precision BioSciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(8.96)
Revenue Per Share
0.069
Quarterly Revenue Growth
(0.98)
Return On Assets
(0.45)
Return On Equity
(2.05)
Precision BioSciences's market price often diverges from its book value, the accounting figure shown on Precision's balance sheet. Smart investors calculate Precision BioSciences' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Precision BioSciences' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
It's important to distinguish between Precision BioSciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Precision BioSciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Precision BioSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY